Boldine reduces left ventricle oxidative stress in isoproterenol-induced adrenergic overload experimental model

Elissa Kerli Fernandes1, Patrick Türck1, Cristina Campos Carraro1

  • 1Laboratory of Cardiovascular Physiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.

Insights

Boldine (BOL) protects the heart from damage caused by sustained adrenergic overload. BOL treatment reduced cardiac hypertrophy and oxidative stress, suggesting a therapeutic role in preventing adverse cardiac remodelling.

Area of Science:

  • Cardiology
  • Pharmacology
  • Oxidative Stress Research

Background:

  • Sustained adrenergic overload leads to maladaptive cardiac remodelling and oxidative stress.
  • Boldine (BOL), an antioxidant, presents a potential therapeutic strategy for cardiac conditions.

Purpose of the Study:

  • To investigate the cardioprotective effects of Boldine (BOL) against isoproterenol (ISO)-induced adverse left ventricular remodelling.
  • To evaluate BOL's impact on cardiac hypertrophy, diastolic dysfunction, and oxidative stress markers.

Main Methods:

  • Rats were divided into control, BOL, isoproterenol (ISO), and ISO + BOL groups.
  • Evaluated morphometric, echocardiographic, and oxidative stress parameters.
  • Assessed lipid peroxidation, superoxide dismutase (SOD), and glutathione-S-transferase (GST) levels.

Main Results:

  • BOL significantly attenuated cardiac hypertrophy and increased diastolic volume induced by ISO (P < 0.05).
  • BOL treatment reduced ISO-induced lipid peroxidation (P < 0.05).
  • BOL administration increased superoxide dismutase (SOD) and glutathione-S-transferase (GST) levels (P < 0.05).

Conclusions:

  • Boldine (BOL) demonstrates cardioprotective effects against isoproterenol-induced cardiac remodelling.
  • BOL may improve cardiac oxidative stress by enhancing antioxidant enzyme activity.
  • BOL shows promise as a therapeutic agent for conditions involving adrenergic overload and cardiac remodeling.

Related Concept Videos

Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Adrenergic Receptors: &#946; Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.5K